EP1492508A4 - Formes posologiques a liberation controlee - Google Patents
Formes posologiques a liberation controleeInfo
- Publication number
- EP1492508A4 EP1492508A4 EP03713882A EP03713882A EP1492508A4 EP 1492508 A4 EP1492508 A4 EP 1492508A4 EP 03713882 A EP03713882 A EP 03713882A EP 03713882 A EP03713882 A EP 03713882A EP 1492508 A4 EP1492508 A4 EP 1492508A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- dosage forms
- controlled release
- release dosage
- controlled
- forms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B30—PRESSES
- B30B—PRESSES IN GENERAL
- B30B11/00—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses
- B30B11/34—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses for coating articles, e.g. tablets
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Mechanical Engineering (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36182102P | 2002-03-04 | 2002-03-04 | |
US361821P | 2002-03-04 | ||
US29161902A | 2002-11-12 | 2002-11-12 | |
US291619 | 2002-11-12 | ||
PCT/US2003/006591 WO2003075893A1 (fr) | 2002-03-04 | 2003-03-03 | Formes posologiques a liberation controlee |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1492508A1 EP1492508A1 (fr) | 2005-01-05 |
EP1492508A4 true EP1492508A4 (fr) | 2009-05-06 |
Family
ID=27807664
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP03713882A Withdrawn EP1492508A4 (fr) | 2002-03-04 | 2003-03-03 | Formes posologiques a liberation controlee |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1492508A4 (fr) |
JP (1) | JP2005524670A (fr) |
KR (1) | KR20100049695A (fr) |
CN (1) | CN1649569B (fr) |
AU (2) | AU2003217909C1 (fr) |
BR (1) | BR0308305A (fr) |
CA (1) | CA2477701A1 (fr) |
EA (1) | EA005866B1 (fr) |
IL (1) | IL163887A0 (fr) |
MX (1) | MXPA04008536A (fr) |
NO (1) | NO20044188L (fr) |
NZ (1) | NZ535083A (fr) |
WO (1) | WO2003075893A1 (fr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0203296D0 (en) | 2002-02-12 | 2002-03-27 | Glaxo Group Ltd | Novel composition |
US20060233875A1 (en) * | 2002-07-19 | 2006-10-19 | Mathur Rajeev S | Taste masked sumatriptan tablets and processes for their preparation |
US8637512B2 (en) | 2002-07-29 | 2014-01-28 | Glaxo Group Limited | Formulations and method of treatment |
EA200500764A1 (ru) * | 2002-11-12 | 2005-12-29 | Тева Фармасьютикал Индастриес Лтд. | Фармацевтические композиции и лекарственные формы для трансбуккальной и сублингвальной доставки тизанидина и способы введения тизанидина сублингвально или трансбуккально |
WO2005046978A1 (fr) * | 2003-11-14 | 2005-05-26 | Sanwa Kagaku Kenkyusho Co., Ltd. | Procede pour la fabrication d'un moulage a noyau |
GB0400452D0 (en) * | 2004-01-09 | 2004-02-11 | Norton Healthcare Ltd | A pharmaceutical composition |
GB0403628D0 (en) * | 2004-02-18 | 2004-03-24 | Arrow Group Ltd | Compression-coated tablets and the manufacture thereof |
EP1715872A1 (fr) * | 2004-02-19 | 2006-11-02 | Teva Pharmaceutical Industries Ltd. | Therapie amelioree utilisant une combinaison de raloxifene et d'alendronate |
KR100701409B1 (ko) | 2004-11-26 | 2007-03-30 | 한국유나이티드제약 주식회사 | 호박산 수마트립탄을 함유하는 약제학적 조성물 |
JP2012500221A (ja) | 2008-08-15 | 2012-01-05 | ディポメド,インコーポレイティド | Cns障害の処理及び予防のための胃保持性医薬組成物 |
CN110368371A (zh) * | 2014-04-08 | 2019-10-25 | 越洋医药开发(广州)有限公司 | 一种新型控释片 |
JP6878417B2 (ja) * | 2016-02-17 | 2021-05-26 | トリアステック インコーポレイテッド | 剤形およびそれらの使用 |
CN110604724A (zh) * | 2019-10-22 | 2019-12-24 | 恒诚制药集团淮南有限公司 | 一种肠溶美沙拉秦缓释片剂及其制备方法 |
WO2024081456A1 (fr) * | 2022-10-13 | 2024-04-18 | Clarke Mosquito Control Products, Inc. | Compositions de comprimés insecticides |
JP2024083720A (ja) * | 2022-12-12 | 2024-06-24 | パナソニックIpマネジメント株式会社 | 水処理用徐放性固形薬剤 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3146169A (en) * | 1960-01-21 | 1964-08-25 | Burroughs Wellcome Co | Pharmaceutical formulations and their manufacture |
EP0205342A2 (fr) * | 1985-06-11 | 1986-12-17 | Pitman-Moore Limited | Systèmes pour libérer une substance active |
WO1996019201A1 (fr) * | 1994-12-22 | 1996-06-27 | Merck & Co., Inc. | Dispositif de liberation controlee d'une suspension medicamenteuse |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61243016A (ja) * | 1985-04-19 | 1986-10-29 | Katsumi Takada | 柱状の有効成分含有部分をもつ錠剤 |
JPS6253918A (ja) * | 1985-09-02 | 1987-03-09 | Katsumi Takada | 柱状の有効成分含有部分を埋没させた錠剤 |
DE4431653C2 (de) * | 1994-09-06 | 2000-01-20 | Lohmann Therapie Syst Lts | Manteltablette zur kontrollierten Freisetzung von Wirkstoffen, ein Verfahren zu ihrer Herstellung und ihre Verwendung |
JP3962108B2 (ja) * | 1995-04-03 | 2007-08-22 | 中外製薬株式会社 | スクラルファート含有製剤組成物 |
CA2184316A1 (fr) * | 1995-09-12 | 1997-03-13 | Wei-Chi Liao | Systeme d'administration buccale pour agents therapeutiques |
DK0931543T3 (da) * | 1997-12-19 | 2002-06-17 | Merck Patent Gmbh | Flerlagstabletter indeholdende probiotiske mikroorganismer såsom lactobacilli eller bifidobakterier |
PL192423B1 (pl) * | 1997-12-22 | 2006-10-31 | Schering Corp | Kompozycja farmaceutyczna typu molekularnej dyspersji |
JP4748839B2 (ja) * | 1999-03-25 | 2011-08-17 | 大塚製薬株式会社 | シロスタゾール製剤 |
US6499984B1 (en) * | 2000-05-22 | 2002-12-31 | Warner-Lambert Company | Continuous production of pharmaceutical granulation |
DE60137082D1 (de) * | 2000-06-28 | 2009-01-29 | Palmetto Pharmaceuticals Llc | Zusammensetzungen von arginin mit kontrollierter freigabe |
WO2003057136A2 (fr) * | 2001-12-24 | 2003-07-17 | Teva Pharmaceutical Industries Ltd. | Forme posologique avec pastille noyau de principe actif enrobee dans un corps annulaire comprime de poudre ou de substance granulaire, et procede et outils pour la production de cette forme posologique |
-
2003
- 2003-03-03 EP EP03713882A patent/EP1492508A4/fr not_active Withdrawn
- 2003-03-03 CA CA002477701A patent/CA2477701A1/fr not_active Abandoned
- 2003-03-03 MX MXPA04008536A patent/MXPA04008536A/es active IP Right Grant
- 2003-03-03 AU AU2003217909A patent/AU2003217909C1/en not_active Ceased
- 2003-03-03 KR KR1020107008536A patent/KR20100049695A/ko not_active Application Discontinuation
- 2003-03-03 CN CN038101068A patent/CN1649569B/zh not_active Expired - Fee Related
- 2003-03-03 NZ NZ535083A patent/NZ535083A/en not_active IP Right Cessation
- 2003-03-03 WO PCT/US2003/006591 patent/WO2003075893A1/fr active Application Filing
- 2003-03-03 BR BR0308305-5A patent/BR0308305A/pt not_active IP Right Cessation
- 2003-03-03 IL IL16388703A patent/IL163887A0/xx unknown
- 2003-03-03 JP JP2003574168A patent/JP2005524670A/ja active Pending
- 2003-03-03 EA EA200401097A patent/EA005866B1/ru not_active IP Right Cessation
-
2004
- 2004-10-01 NO NO20044188A patent/NO20044188L/no not_active Application Discontinuation
-
2009
- 2009-01-30 AU AU2009200353A patent/AU2009200353A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3146169A (en) * | 1960-01-21 | 1964-08-25 | Burroughs Wellcome Co | Pharmaceutical formulations and their manufacture |
EP0205342A2 (fr) * | 1985-06-11 | 1986-12-17 | Pitman-Moore Limited | Systèmes pour libérer une substance active |
WO1996019201A1 (fr) * | 1994-12-22 | 1996-06-27 | Merck & Co., Inc. | Dispositif de liberation controlee d'une suspension medicamenteuse |
Non-Patent Citations (1)
Title |
---|
See also references of WO03075893A1 * |
Also Published As
Publication number | Publication date |
---|---|
CN1649569A (zh) | 2005-08-03 |
NZ535083A (en) | 2007-06-29 |
EA005866B1 (ru) | 2005-06-30 |
AU2003217909C1 (en) | 2009-06-11 |
AU2003217909A1 (en) | 2003-09-22 |
CA2477701A1 (fr) | 2003-09-18 |
IL163887A0 (en) | 2005-12-18 |
CN1649569B (zh) | 2010-05-05 |
EA200401097A1 (ru) | 2005-04-28 |
KR20100049695A (ko) | 2010-05-12 |
EP1492508A1 (fr) | 2005-01-05 |
JP2005524670A (ja) | 2005-08-18 |
BR0308305A (pt) | 2004-12-28 |
WO2003075893A1 (fr) | 2003-09-18 |
MXPA04008536A (es) | 2005-09-08 |
AU2003217909B2 (en) | 2008-10-30 |
NO20044188L (no) | 2004-12-03 |
AU2009200353A1 (en) | 2009-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI347202B (en) | Controlled release preparation | |
IL174343A0 (en) | Delayed released dosage forms | |
GB0217225D0 (en) | Medicinal compounds | |
GB0225540D0 (en) | Medicinal compounds | |
GB0204719D0 (en) | Medicinal compounds | |
GB0225535D0 (en) | Medicinal compounds | |
GB0220730D0 (en) | Medicinal compounds | |
GB0225030D0 (en) | Medicinal compounds | |
EP1553925A4 (fr) | Forme posologique orale a liberation modifiee | |
IL163887A0 (en) | Controlled release dosage forms | |
AU2003215150A8 (en) | Therapeutic compounds | |
AU2003261067A8 (en) | Modified release ketoprofen dosage form | |
AU2003255890A8 (en) | Nitrofurantoin controlled release dosage form | |
GB0208392D0 (en) | Therapeutic compounds | |
AU2003220479A1 (en) | Modified release dosage forms | |
GB0211444D0 (en) | Controlled release formulations | |
GB0215656D0 (en) | Controlled release composition | |
GB0225025D0 (en) | Medicinal compounds | |
GB0224508D0 (en) | Medicinal compounds | |
GB0225031D0 (en) | Medicinal compounds | |
GB0215930D0 (en) | Medicinal compounds | |
GB0224498D0 (en) | Medicinal compounds | |
GB0224502D0 (en) | Medicinal compounds | |
GB0225027D0 (en) | Medicinal compounds | |
GB0225536D0 (en) | Medicinal compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20040901 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1067063 Country of ref document: HK |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20090402 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: B30B 11/08 20060101ALI20090327BHEP Ipc: B29C 43/20 20060101ALI20090327BHEP Ipc: A61K 9/30 20060101ALI20090327BHEP Ipc: A61K 9/28 20060101ALI20090327BHEP Ipc: A61K 9/24 20060101AFI20090327BHEP |
|
17Q | First examination report despatched |
Effective date: 20090616 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1067063 Country of ref document: HK |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20121002 |